A Machine Learning Model to Predict Drug Transfer Across the Human Placenta Barrier

被引:15
|
作者
Di Filippo, Juan, I [1 ,2 ,3 ,4 ]
Bollini, Mariela [5 ]
Cavasotto, Claudio N. [1 ,2 ,3 ,4 ]
机构
[1] Univ Austral, CONICET, Inst Invest Med Traslac IIMT, Computat Drug Design & Biomed Informat Lab, Pilar, Argentina
[2] Univ Austral, Fac Ciencias Biomed, Pilar, Argentina
[3] Univ Austral, Fac Ingn, Pilar, Argentina
[4] Univ Austral, Austral Inst Appl Artificial Intelligence, Pilar, Argentina
[5] Consejo Nacl Invest Cient & Tecn, Ctr Invest BioNanociencias CIBION, Buenos Aires, DF, Argentina
来源
FRONTIERS IN CHEMISTRY | 2021年 / 9卷
关键词
placenta barrier permeability; machine learning; toxicology; clearence index; fetus; mother ratio; PERFUSION MODEL;
D O I
10.3389/fchem.2021.714678
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The development of computational models for assessing the transfer of chemicals across the placental membrane would be of the utmost importance in drug discovery campaigns, in order to develop safe therapeutic options. We have developed a low-dimensional machine learning model capable of classifying compounds according to whether they can cross or not the placental barrier. To this aim, we compiled a database of 248 compounds with experimental information about their placental transfer, characterizing each compound with a set of similar to 5.4 thousand descriptors, including physicochemical properties and structural features. We evaluated different machine learning classifiers and implemented a genetic algorithm, in a five cross validation scheme, to perform feature selection. The optimization was guided towards models displaying a low number of false positives (molecules that actually cross the placental barrier, but are predicted as not crossing it). A Linear Discriminant Analysis model trained with only four structural features resulted to be robust for this task, exhibiting only one false positive case across all testing folds. This model is expected to be useful in predicting placental drug transfer during pregnancy, and thus could be used as a filter for chemical libraries in virtual screening campaigns.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Transfer of Trastuzumab® across the human placenta barrier
    Radisic, V. Bjelic
    Gruber, M. M.
    Hirschmugl, B.
    Wadsack, C.
    CANCER RESEARCH, 2016, 76
  • [2] Mechanisms of drug transfer across the human placenta
    van der Aa, EM
    Peereboom-Stegman, JHJC
    Noordhoek, J
    Gribnau, FWJ
    Russel, FGM
    PHARMACY WORLD & SCIENCE, 1998, 20 (04): : 139 - 148
  • [3] Mechanisms of drug transfer across the human placenta.
    Eric M. van der Aa
    Jenny H.J. Copius Peereboom-Stegeman
    Jan Noordhoek
    Frank W.J. Gribnau
    Frans G.M. Russel
    Pharmacy World and Science, 1998, 20 : 139 - 148
  • [4] Mechanisms of drug transfer across the human placenta - A workshop report
    St-Pierre, MV
    Ugele, B
    Gambling, L
    Shiverick, KT
    PLACENTA, 2002, 23 : S159 - S164
  • [5] Pharmacology of drug transfer across the placenta
    Garland, M
    OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA, 1998, 25 (01) : 21 - +
  • [6] TRANSFER OF NITROFURANTOIN ACROSS HUMAN PLACENTA
    PERRY, JE
    LEBLANC, AL
    TEXAS REPORTS ON BIOLOGY AND MEDICINE, 1967, 25 (02) : 265 - &
  • [8] Transfer of Gangliosides across the Human Placenta
    Henare, Kimiora
    Lowe, Edwin
    Naylor, Melanie
    Fong, Bertram
    McJarrow, Paul
    Mitchell, Murray D.
    REPRODUCTIVE SCIENCES, 2009, 16 (03) : 345A - 345A
  • [9] TRANSFER OF NITRAZEPAM ACROSS HUMAN PLACENTA
    KANGAS, L
    KANTO, J
    ERKKOLA, R
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1977, 12 (05) : 355 - 357
  • [10] Transfer of gangliosides across the human placenta
    Mitchell, M. D.
    Henare, K.
    Lowe, E.
    Naylor, M.
    Fong, B.
    McJarrow, P.
    EARLY HUMAN DEVELOPMENT, 2007, 83 : S149 - S149